Qynapse
PrivateLast Round
Series A
Jun 1, 2021
Total Funding Raised
$6.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qynapse operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in June 2021.
Qynapse is a medical technology company that develops and commercializes an AI-powered and proprietary neuroimaging software platform for the diagnosis and monitoring of central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qynapse Comparables
Compare Qynapse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Darmiyan | 86% | |
| Brainreader | 86% | |
| In-Med Prognostics | 85% |
For institutional investors. Book with your work email.
Qynapse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2021 | ||||
| M&A | Oct 13, 2020 | ||||
| Seed | May 2, 2018 | ||||
| Seed | Jul 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qynapse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Seed |
| GO Capital | Seed |
| Normandie Participations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 448% MoM.
- Jul 27, 2026
Open roles increased to 91, 4.14x headcount and 4.9x trailing average.
For institutional investors. Book with your work email.
Qynapse Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qynapse's valuation, stock price, and market status.
Is Qynapse a public or private company?
Qynapse is a private company.
What is the current stock price of Qynapse?
Qynapse is a private company, so its shares have no public market price. Caplight tracks Qynapse's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qynapse worth (valuation)?
Valuation information for Qynapse is not publicly available.
Can I buy Qynapse stock?
Qynapse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qynapse's last funding round?
Qynapse's most recent funding round was Series A on June 1, 2021.
Who are the main investors in Qynapse?
Key investors in Qynapse include GO Capital.
Will Qynapse IPO soon?
No public IPO plans have been announced for Qynapse.
How can I track Qynapse secondary market activity?
Caplight tracks bids, offers, and trades in Qynapse's shares on secondary markets.